Evaluation of TAZ expression and its effect on tumor invasion and metastasis in human glioma

Asian Pacific Journal of Tropical Medicine

Volumn 7, Issue 10, 2014, Pages 757-760

  Li, Pei Dong ^a   Wang, Xin Jun ^a   Shan, Qiao ^a   Wu, Yue Hui ^a   Wang, Zhen ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Clinical significance; Glioma; Invasion; Metastasis; TAZ

Indexed keywords

PROTEIN; SHORT HAIRPIN RNA; TAZ PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CANCER GRADING; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROSPECTIVE STUDY; TUMOR INVASION; WESTERN BLOTTING;

EID: 84905965688     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(14)60131-0     Document Type: Article

References (25)

1. Pei J, Moon KS, Pan S, Lee KH, Ryu HH, Jung TY, et al. Proteomic analysis between U87MG and U343MG-A cell lines: searching for candidate proteins for glioma invasion. Brain Tumor Res Treat 2014, 2:22-28.
2. Tsutsumi R, Masoudi M, Takahashi A, Fujii Y, Hayashi T, Kikuchi I, et al. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. Dev Cell 2013, 26:658-665.
3. Zhao B, Lei QY, Guan KL The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 2008, 20:638-646.
4. Pan D The hippo signaling pathway in development and cancer. Dev Cell 2010, 19:491-505.
5. Halder G, Johnson RL Hippo signaling: growth control and beyond. Development 2011, 138:9-22.
6. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474(7350):179-183.
7. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309(5737):1074-1078.
8. Murakami M, Nakagawa M, Olson EN, Nakagawa O A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci U S A 2005, 102(50):18034-18039.
9. Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, Nakagawa O, et al. Transcriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun 2006, 339(2):533-539.
10. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 2008, 10(7):837-848.
11. Di Palma T, D'Andrea B, Liguori GL, Liguoro A, de Cristofaro T, Del Prete D, et al. TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Exp Cell Res 2009, 315(2):162-175.
12. Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S, et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 2009, 284(20):13355-13362.
13. Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X, et al. Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep 2013, 5(6):1611-1624.
14. Varelas X The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 2014, 141(8):1614-1626.
15. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 2008, 68(8):2592-2598.
16. Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 2011, 30(18):2181-2186.
17. Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One 2013, 8(6):e65539.
18. Yue G, Sun X, Gimenez-Capitan A, Shen J, Yu L, Teixido C, et al. TAZ is highly expressed in gastric signet ring cell carcinoma. Biomed Res Int 2014, 10.1155/2014/393064.
19. Han SX, Bai E, Jin GH, He CC, Guo XJ, Wang LJ, et al. Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma. J Immunol Res 2014, 10.1155/2014/261365.
20. Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, et al. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Mol Cancer 2014, 13:110.
21. Zhao B, Li L, Lei Q, Guan KL The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 2010, 24(9):862-874.
22. Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 2011, 25(24):2594-2609.
23. Katsuno Y, Lamouille S, Derynck R TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 2013, 25(1):76-84.
24. Mahabir R, Tanino M, Elmansuri A, Wang L, Kimura T, Itoh T, et al. Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro Oncol 2014, 16(5):671-685.
25. Yan YR, Xie Q, Li F, Zhang Y, Ma JW, Xie SM, et al. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells. Neuropathology 2014, 34(2):128-134.